These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8341023)
1. Improvement of ischemic myocardial dysfunction by nisoldipine in relation to its coronary vasodilating action. Umeda M; Saida K Jpn J Pharmacol; 1993 May; 62(1):1-7. PubMed ID: 8341023 [TBL] [Abstract][Full Text] [Related]
2. Improvement of ischemic myocardial dysfunction by nisoldipine. Saida K; Umeda M; Itakura A Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():365-70. PubMed ID: 7947379 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of nifedipine and nisoldipine on coronary vasoconstriction in the Langendorff-perfused rat heart. Okada T; Izawa N; Nakamura T J Cardiovasc Pharmacol; 2000 Jan; 35(1):145-9. PubMed ID: 10630745 [TBL] [Abstract][Full Text] [Related]
4. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. Ehring T; Böhm M; Heusch G J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion. Bernstein EA; Eberli FR; Silverman AM; Horowitz GL; Apstein CS Cardiovasc Drugs Ther; 1996 May; 10(2):167-78. PubMed ID: 8842509 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart. Pijl AJ; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127 [TBL] [Abstract][Full Text] [Related]
7. Nisoldipine selectively induces coronary vasodilation and improves mild myocardial ischemia in dogs: a potential role of cellular acidosis. Kitakaze M; Funaya H; Komamura K; Node K; Minamino T; Mori H; Takeda H; Kuzuya T; Hori M Cardiovasc Drugs Ther; 1998 Dec; 12(6):533-41. PubMed ID: 10410823 [TBL] [Abstract][Full Text] [Related]
8. Ventricular function and calcium handling during ischemia. Amende I; Bentivegna L; Morgan JP J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S42. PubMed ID: 1282612 [TBL] [Abstract][Full Text] [Related]
9. Effects of nisoldipine on the no-reflow phenomenon in globally ischemic rat hearts. Watts JA; Hawes EM; Jenkins SH; Williams TC J Cardiovasc Pharmacol; 1990 Sep; 16(3):487-94. PubMed ID: 1700222 [TBL] [Abstract][Full Text] [Related]
10. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494 [TBL] [Abstract][Full Text] [Related]
11. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion. Becker BF; Möbert J Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553 [TBL] [Abstract][Full Text] [Related]
13. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts. Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080 [TBL] [Abstract][Full Text] [Related]
15. A low concentration of nisoldipine reduces ischemic heart injury: enhanced reflow and recovery of contractile function without energy preservation during ischemia. Watts JA; Whipple JP; Hatley AA J Mol Cell Cardiol; 1987 Aug; 19(8):809-16. PubMed ID: 3694681 [TBL] [Abstract][Full Text] [Related]
16. Energy preserving effect of l-cis diltiazem in isolated ischemic and reperfused guinea pig hearts: a 31P-NMR study. Sakamoto K; Ishikawa M; Koga K; Urushidani T; Nagao T Jpn J Pharmacol; 2000 Jul; 83(3):225-32. PubMed ID: 10952071 [TBL] [Abstract][Full Text] [Related]
17. Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid components. Tanguay M; Lepage G; Blaise G; Garceau D; Dumont L J Cardiovasc Pharmacol; 1994 Dec; 24(6):950-9. PubMed ID: 7898079 [TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion? Ehring T; Heusch G Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166 [TBL] [Abstract][Full Text] [Related]
19. Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine. Direct observations in isolated rat hearts. McDonagh PF; Roberts DJ Circ Res; 1986 Jan; 58(1):127-36. PubMed ID: 3080259 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Weselcouch EO; Baird AJ; Sleph P; Grover GJ Am J Physiol; 1995 Jan; 268(1 Pt 2):H242-9. PubMed ID: 7530919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]